Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-6 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Arthritis, Rheumatoid 1 D001172 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109614